Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193,394,759
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
24,142,348
-
Shares change
-
+1,874,034
-
Total reported value, excl. options
-
$75,528,504
-
Value change
-
+$7,771,699
-
Put/Call ratio
-
150%
-
Number of buys
-
37
-
Number of sells
-
28
-
Price
-
$3.13
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2020
As of 30 Sep 2020 Arbutus Biopharma Corp - Common Shares, without par value (ABUS) had 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,142,348 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, Foresite Capital Management IV, LLC, MORGAN STANLEY, VANGUARD GROUP INC, Think Investments LP, ADVISOR GROUP HOLDINGS, INC., BlackRock Inc., Hudson Bay Capital Management LP, AMERIPRISE FINANCIAL INC, and PRIMECAP MANAGEMENT CO/CA/.
This table shows 60 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.